Simulations Plus (NASDAQ:SLP) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

Simulations Plus, Inc. (NASDAQ:SLP) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $15.56 and traded as high as $18.27. Simulations Plus shares last traded at $18.15, with a volume of 632,074 shares trading hands.

Analyst Upgrades and Downgrades

Several research firms have commented on SLP. William Blair downgraded shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. Wall Street Zen cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. Craig Hallum downgraded shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price objective on the stock. in a report on Thursday, June 18th. TD Cowen cut their price objective on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Finally, Weiss Ratings upgraded shares of Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, June 5th. One investment analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $20.90.

Simulations Plus Stock Performance

The business’s 50 day moving average price is $15.64 and its 200-day moving average price is $15.55. The company has a market cap of $366.43 million, a price-to-earnings ratio of -5.80 and a beta of 1.33.

Simulations Plus (NASDAQ:SLP) last posted its earnings results on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.08. The business had revenue of $24.29 million for the quarter, compared to analysts’ expectations of $21.66 million. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. On average, equities research analysts expect that Simulations Plus, Inc. will post 0.8 earnings per share for the current fiscal year.

Institutional Trading of Simulations Plus

Several institutional investors have recently bought and sold shares of the stock. Raymond James Financial Inc. acquired a new position in Simulations Plus during the second quarter worth $25,000. Quarry LP bought a new stake in shares of Simulations Plus in the 3rd quarter worth about $28,000. Caitong International Asset Management Co. Ltd grew its holdings in shares of Simulations Plus by 343.0% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,983 shares of the technology company’s stock worth $73,000 after purchasing an additional 3,084 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Simulations Plus by 59.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 4,485 shares of the technology company’s stock worth $53,000 after purchasing an additional 1,669 shares in the last quarter. Finally, Fifth Third Bancorp acquired a new stake in shares of Simulations Plus during the 1st quarter worth about $54,000. Institutional investors and hedge funds own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.